Quality Control in the Microbiology Laboratory: Key Practices for Reliable Results

Quality control (QC) in the microbiology laboratory is a systematic program of checks, tests, and documentation designed to verify that reagents, media, equipment, and procedures perform within established specifications, ensuring that reported results are accurate, reproducible, and clinically meaningful. This practice is essential for any laboratory performing microbiological testing, from teaching and research settings to clinical diagnostic laboratories, as it detects technical variability before it compromises data integrity. QC is particularly useful when implementing new tests, training personnel, validating laboratory-developed methods, and maintaining ongoing confidence in routine workflows. Without robust QC, subtle shifts in antimicrobial susceptibility testing (AST) results—such as those described by Zaydman et al. in their analysis of daptomycin susceptibility trends [1]—can go undetected, leading to erroneous clinical decisions or research conclusions.

At a Glance

Scientific Principle of Quality Control

Quality control in microbiology operates on the principle that every variable in the testing process—from media composition to incubation conditions—can introduce error. The goal is to minimize both random error (imprecision) and systematic error (bias) through standardized procedures and periodic verification. The foundation of QC rests on the use of well-characterized reference strains with known phenotypic properties. When these strains are tested alongside patient or research samples, any deviation from expected results signals a problem in the testing system.

The importance of this principle was demonstrated by Zaydman et al., who identified a systematic shift in daptomycin susceptibility testing between 2022 and 2025 that was undetectable through routine QC processes [1]. Their analysis revealed that traditional QC metrics, in isolation, can miss subtle but clinically relevant changes in AST performance. This finding underscores the need for comprehensive QC programs that integrate multiple data sources, including patient isolate results, to detect technical variability.

Materials and Instrumentation

Culture Media

Media selection and QC are critical because media composition directly affects microbial growth and biochemical reactions. Laboratories must document for each medium:

• Lot number and expiration date: Record upon receipt and before each use
• Sterility testing: Incubate a representative sample (typically 5-10% of each batch) at appropriate temperatures for 48-72 hours to confirm no contamination
• Performance testing: Inoculate with QC strains to verify that the medium supports growth of target organisms and inhibits non-target organisms (for selective media) and produces expected biochemical reactions (for differential media)

For resource-limited settings, Amorim et al. describe a frugal-circular framework that uses household ingredients and improvised equipment while maintaining scientific rigor [5]. This approach demonstrates that effective QC can be achieved even without commercial media, provided that sterilization, sterility testing, and performance verification are maintained.

Reagents and Stains

All reagents used in microbiological testing—including Gram stain reagents, oxidase reagent, catalase reagent, and biochemical test substrates—require QC:

• Upon receipt: Verify lot number, expiration, and physical appearance (color, clarity, absence of precipitation)
• With each new lot: Test with appropriate positive and negative control organisms
• Periodically: For reagents with extended shelf life, test at defined intervals (e.g., monthly for Gram stain reagents)

Equipment

Critical equipment requiring regular monitoring includes:

The CDC and NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL) provides authoritative guidance on equipment maintenance and decontamination procedures [6]. For biosafety cabinets, daily pre-use checks should include verifying airflow indicators and ensuring the sash is at the correct height.

Controls

Positive and Negative Controls

Every test run should include:

• Positive control: A strain known to produce the expected positive result (e.g., Staphylococcus aureus ATCC 25923 for coagulase testing)
• Negative control: A strain known to produce the expected negative result (e.g., Escherichia coli ATCC 25922 for coagulase testing)
• Sterility control: Uninoculated medium incubated under the same conditions to detect contamination

For AST, QC strains with defined minimum inhibitory concentration (MIC) ranges are essential. The Clinical and Laboratory Standards Institute (CLSI) publishes tables of acceptable QC ranges for each antimicrobial agent-organism combination. Laboratories must test these strains weekly or with each new lot of media or antimicrobial disks.

Reference Strain Management

Proper maintenance of QC strains is critical for reliable results:

• Source: Obtain from reputable culture collections (ATCC, NCTC, DSMZ)
• Storage: Maintain stock cultures at -70°C or in lyophilized form; working cultures can be stored on appropriate agar slants at 2-8°C for up to one month
• Subculturing: Limit to no more than five passages from the stock culture to prevent phenotypic drift
• Verification: Periodically confirm strain identity and expected resistance/susceptibility patterns

Conceptual Workflow

Step 1: Establish QC Protocols

Before any testing begins, develop written standard operating procedures (SOPs) that specify:

• Which QC strains to use for each test
• Acceptable results and ranges
• Frequency of QC testing
• Corrective actions when QC fails
• Documentation requirements

Step 2: Prepare and Verify Materials

For each batch of media or reagents:

1. Record lot numbers, preparation dates, and expiration dates
2. Perform sterility testing on a representative sample
3. Inoculate QC strains to verify performance
4. Document results and approve batch for use only if all criteria are met

Step 3: Perform Daily Equipment Checks

At the start of each workday:

1. Record incubator, refrigerator, and freezer temperatures
2. Verify biosafety cabinet airflow
3. Check that all equipment is within acceptable ranges
4. If any parameter is out of range, initiate corrective action immediately

Step 4: Run Controls with Each Test Batch

For every testing session:

1. Include appropriate positive and negative controls
2. Include sterility controls for media
3. Process controls identically to test samples
4. Read and interpret controls before reporting any test results

Step 5: Document and Review Results

Maintain comprehensive records including:

• Daily temperature logs
• Media and reagent QC records
• Control results for each test run
• Corrective action reports for any QC failures
• Annual review of QC data to identify trends

Step 6: Analyze Trends

As highlighted by Zaydman et al., routine QC processes may miss subtle shifts [1]. Laboratories should periodically analyze aggregated QC data and patient isolate results to detect trends that might indicate technical problems. This can be done through:

• Levey-Jennings charts for quantitative results (e.g., MIC values)
• Monthly or quarterly reviews of susceptibility rates
• Comparison of results across different testing methods or instruments

Quality Checks and Verification

Media Performance Testing

For each new batch of medium, test with appropriate QC strains:

• Non-selective media (e.g., blood agar, nutrient agar): Verify that QC strains show expected colony morphology and growth characteristics
• Selective media (e.g., MacConkey agar, mannitol salt agar): Verify that target organisms grow and non-target organisms are inhibited
• Differential media (e.g., EMB agar, XLD agar): Verify that expected biochemical reactions occur

Reagent QC

• Gram stain: Test with Staphylococcus aureus (gram-positive cocci) and Escherichia coli (gram-negative rods) daily or with each use
• Oxidase reagent: Test with Pseudomonas aeruginosa (positive) and Escherichia coli (negative)
• Catalase reagent: Test with Staphylococcus aureus (positive) and Enterococcus faecalis (negative)

Equipment Verification

• Autoclave: Use biological indicators (e.g., Geobacillus stearothermophilus spores) at least monthly; chemical indicators with each cycle
• Incubators: Verify CO₂ levels if using CO₂ incubators; check humidity if specified
• Pipettes: Calibrate annually or per laboratory policy; check accuracy gravimetrically

Result Interpretation

Acceptable QC Results

QC results are acceptable when:

• Positive controls show expected growth, biochemical reactions, or susceptibility patterns
• Negative controls show no growth or expected negative reactions
• Sterility controls show no growth
• Quantitative results (e.g., MIC values, zone diameters) fall within established acceptable ranges

Unacceptable QC Results

When QC results are out of range:

1. Do not report patient or research results from that test run
2. Investigate potential causes (see Troubleshooting table)
3. Document the failure and corrective actions taken
4. Repeat QC testing after corrective action
5. If repeat QC passes, re-test any affected samples
6. If repeat QC fails again, escalate to supervisor and consider replacing reagents or media

Trend Analysis

Even when individual QC results are within range, trend analysis may reveal emerging problems. For example, Zaydman et al. described a subtle shift in daptomycin AST results that led to a 5-22% decrease in susceptibility rates for certain organisms, particularly Enterococcus faecium [1]. This shift was only detectable through systematic review of patient data, not through routine QC processes. Laboratories should therefore:

• Monitor susceptibility rates over time for common organism-drug combinations
• Investigate any sustained changes that cannot be explained by epidemiologic shifts
• Consider implementing statistical process control charts for key QC parameters

Troubleshooting

Limitations

Quality control in microbiology has several inherent limitations that users must understand:

1. QC detects problems but does not prevent them: QC is a verification step, not a preventive measure. Good laboratory practices, proper training, and equipment maintenance are equally important.

2. QC strains may not represent all clinical isolates: Reference strains have known properties, but they may not detect problems that affect only certain organism types or resistance mechanisms.

3. Subtle shifts can be missed: As demonstrated by Zaydman et al., traditional QC metrics may not detect gradual, systematic changes in test performance [1]. Laboratories need complementary approaches, such as patient data analysis, to identify these shifts.

4. QC adds time and cost: Each QC test consumes materials, personnel time, and incubator space. Laboratories must balance thorough QC with operational efficiency.

5. Inter-laboratory variability: Even with standardized QC protocols, results can vary between laboratories due to differences in equipment, reagents, and technique. Participation in external quality assessment (proficiency testing) programs helps address this.

6. Resource constraints: In low-resource settings, implementing comprehensive QC may be challenging. The frugal-circular framework described by Amorim et al. offers alternatives using improvised equipment and household ingredients, but these approaches require careful validation [5].

Documentation

Comprehensive documentation is the backbone of an effective QC program. Essential records include:

Daily Records

• Temperature logs for all incubators, refrigerators, and freezers
• Biosafety cabinet pre-use checklist
• pH meter calibration log
• Balance calibration log

Batch Records

• Media preparation records (ingredients, lot numbers, preparation date, sterilization conditions, pH)
• Media QC results (sterility testing, performance testing with QC strains)
• Reagent preparation and QC records

Test Records

• Control results for each test run (positive, negative, sterility)
• Corrective action reports for any QC failures
• Annual review of QC data

Equipment Records

• Maintenance logs
• Calibration certificates
• Repair records

Training Records

• Personnel training on QC procedures
• Competency assessments
• Annual updates

The NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules emphasize the importance of documentation for institutional biosafety and compliance [7]. While these guidelines specifically address recombinant DNA research, the principle of thorough documentation applies broadly to all microbiology laboratory QC.

Biosafety Considerations

Quality control procedures must be performed in accordance with appropriate biosafety practices. For BSL-1 teaching laboratories using safe organisms (e.g., Escherichia coli K-12, Saccharomyces cerevisiae, non-pathogenic Bacillus species), standard microbiological practices apply:

• Hand washing after handling cultures and before leaving the laboratory
• No eating, drinking, or applying cosmetics in the laboratory
• Decontamination of work surfaces daily and after spills
• Proper waste disposal (autoclaving before disposal)
• Use of personal protective equipment (lab coat, gloves, safety glasses)

The BMBL provides authoritative guidance on risk assessment and containment for different biosafety levels [6]. For laboratories working with clinical isolates or environmental samples of unknown pathogenicity, BSL-2 practices are required, including:

• Biosafety cabinet use for procedures that may generate aerosols
• Restricted access during work
• Sharps precautions
• Spill response protocols

Amorim et al. emphasize the precautionary rule "unknown = potentially pathogenic" for environmental samples in teaching settings [5]. This principle applies equally to QC strains: even though reference strains are generally safe, they should be handled with appropriate containment and decontamination procedures.

Frequently Asked Questions

1. How often should QC strains be subcultured before they need to be replaced?

QC strains should be subcultured no more than five times from the original stock culture. Each subculture increases the risk of phenotypic drift, contamination, or loss of viability. Maintain a frozen stock at -70°C or lyophilized stock for long-term storage, and prepare fresh working cultures from this stock as needed. For routine weekly QC, prepare a fresh subculture from the stock culture every month.

2. What should I do if my QC results are within range but I notice a trend toward the upper or lower limit?

This situation warrants investigation even though individual results are acceptable. Plot your QC data on a Levey-Jennings chart to visualize trends. If you observe a consistent drift in one direction, check for potential causes such as reagent aging, incubator temperature drift, or changes in media preparation. Consider testing with a fresh lot of reagents or media to determine if the trend is due to material degradation. Document your findings and consider implementing more frequent QC testing until the trend stabilizes.

3. Can I use clinical isolates as QC strains instead of ATCC reference strains?

Clinical isolates should not replace ATCC reference strains for routine QC because their properties may change over time and they lack the extensive characterization of reference strains. However, clinical isolates can be useful as supplemental controls for specific tests or as teaching tools. If you use clinical isolates, you must verify their identity and expected properties regularly. For AST QC, only ATCC strains with published acceptable ranges should be used.

4. How do I handle QC failures when I have already reported patient results?

If a QC failure is discovered after patient results have been reported, immediately notify the laboratory supervisor and the requesting clinician. Document the QC failure and the time period during which it occurred. Assess whether the failure could have affected patient results (e.g., if the QC failure indicates a systematic error in AST, all AST results from that run are suspect). Depending on the nature of the failure, you may need to repeat testing on stored isolates or request new specimens. Implement corrective actions to prevent recurrence, and document the entire process in the laboratory's quality management system.

References and Further Reading

1. Zaydman MA, Glaser L, Herman DS, et al. Leveraging patient data to detect systematic shifts in daptomycin susceptibility testing associated with reduced prescribing. 2026. PubMed
2. Arnaboldi PM, Becker J, Nath A, et al. Designing studies for post-treatment Lyme disease and other infection-associated chronic illnesses. 2026. PubMed
3. El-Shazly MYM, Buonamassa R, Cornelli A, et al. Surgical Site Infections in Mozambique: A Literature Review of Incidence, Antimicrobial Resistance, Risk Factors, and Surveillance Practices. 2026. PubMed
4. Kirby JE, Arnaout R. Why are we doing this alone? A collaborative framework for LDT development and validation. 2026. PubMed
5. Amorim L, Timmis K, da Silva Lopes B, et al. Eco-Microbiology: A Frugal-Circular Framework for Biosafe, Low-Cost Practical Microbiology in Secondary Education. 2026. PubMed
6. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. U.S. Department of Health and Human Services, 2020. CDC
7. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. NIH Office of Science Policy
8. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. NCBI Bookshelf

Related Articles

• Contamination Control in the Microbiology Lab: Sources, Prevention, and Detection
• Quality Control Strains for Antimicrobial Susceptibility Testing: Selection and Maintenance
• How to Perform a Kirby-Bauer Disk Diffusion Test: Protocol and Quality Control
• Biosafety Cabinet Types and Selection Guide for Microbiology Laboratories
• How to Perform a KOH Test for Gram Reaction: Principle and Protocol
• Laboratory Disinfection Procedures: Choosing and Using Disinfectants Effectively